Skip to search boxSkip to navigationSkip to main content

Macro- and micronutrients in African-Americans with heart failure

  • Syamal K. Bhattacharya
    ,
  • Robert A. Ahokas
    ,
  • ,
  • Kevin P. Newman
    ,
  • Ivan C. Gerling
    ,
  • Yao Sun
*Corresponding author for this work
  • University of Tennessee Health Science Center
    ,
  • Department of Veterans Affairs
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

An emerging body of evidence suggests secondary hyperparathyroidism (SHPT) may be an important covariant of congestive heart failure (CHF), especially in African-Americans (AA) where hypovitaminosis D is prevalent given that melanin, a natural sunscreen, mandates prolonged exposure of skin to sunlight and where a housebound lifestyle imposed by symptomatic CHF limits outdoor activities and hence sunlight exposure. In addition to the role of hypovitaminosis D in contributing to SHPT is the increased urinary and fecal losses of macronutrients Ca2+ and Mg2+ associated with the aldosteronism of CHF and their heightened urinary losses with furosemide treatment of CHF. Thus, a precarious Ca2+ balance seen with reduced serum 25(OH)D is further compromised when AA develop CHF with circulating RAAS activation and are then treated with a loop diuretic. SHPT accounts for a paradoxical Ca2+ overloading of diverse tissues and the induction of oxidative stress at these sites which spills over to the systemic circulation. In addition to SHPT, hypozincemia and hyposelenemia have been found in AA with compensated and decompensated heart failure and where an insufficiency of these micronutrients may have its origins in inadequate dietary intake, altered rates of absorption or excretion and/or tissue redistribution, and treatment with an ACE inhibitor or AT1 receptor antagonist. Zn and Se deficiencies, which compromise the activity of several endogenous antioxidant defenses, could prove contributory to the severity of heart failure and its progressive nature. These findings call into question the need for nutriceutical treatment of heart failure and which is complementary to today's pharmaceuticals, especially in AA.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 45-55 (11 pages)

Journal (Volume, Issue Number)

Heart Failure Reviews (Volume 11, Issue 1)

Publication milestones

  • Published - 03/2006

Publication status

Published - 03/2006

ISSN

1382-4147

Publication IDs

  • Scopus: 33745617699
  • PubMed: 16819577

Publication metrics

Metrics

Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1
SciVal
citations
25
Scopus
citations
SciVal
FWCI
0.60
SciVal
Author count
7
SciVal
Paper percentile
77

PlumX, opens in new tab

Citation count
25
Captures
39

Funding Details

FunderFunding number
NHLBI
R01HL073043